IL6R and autoimmune disease: For example, IL6R and IL12A encode direct or indirect targets of approved drugs – Tocilizumab and Ustekinumab – for autoimmune diseases like RA (Sanmartí et al., 2018) and CD (Khanna and Feagan, 2013).